Page last updated: 2024-10-31

neostigmine and Gastric Diseases

neostigmine has been researched along with Gastric Diseases in 3 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butvin, GK2
Zaĭdman, VE2
Moldovan, VI2
Pecheniuk, VN1
Kavkalo, NN1
Nesterenko, NP1
Frank, P1
Eisenbeth, R1

Other Studies

3 other studies available for neostigmine and Gastric Diseases

ArticleYear
[Use of cerucal and galanthamine in the x-ray diagnosis of stomach and duodenal diseases].
    Sovetskaia meditsina, 1981, Issue:7

    Topics: Adult; Aged; Diagnosis, Differential; Duodenal Diseases; Female; Galantamine; Humans; Male; Metoclop

1981
[X-ray diagnosis of gastroduodenal diseases with the use of pharmacological agents].
    Sovetskaia meditsina, 1976, Issue:8

    Topics: Adolescent; Adult; Aged; Duodenal Diseases; Female; Humans; Male; Middle Aged; Morphine; Neostigmine

1976
[Treatment and prevention of acute troplegia after vagotomy by intravenous prostigmine].
    La Presse medicale, 1969, Jun-07, Volume: 77, Issue:28

    Topics: Gastric Dilatation; Injections, Intravenous; Neostigmine; Paralysis; Stomach Diseases; Vagotomy

1969